Live
FierceBiotechMarch M&A surge triggers high expectations for 2026FierceBiotechBuoyed by $100M Series A, Stipple Bio debuts to advance lead oncology asset into clinicFierceBiotechHow ctDNA is redefining MRD monitoring in hematologic cancersEndpoints NewsNeurocrine will pay $2.9B for Soleno and its Prader-Willi medicineWatersQuilter Plc Has $13.04 Million Stock Holdings in Waters Corporation $WAT - MarketBeatThermo FisherThermo Fisher Scientific Inc. $TMO Shares Sold by Rathbones Group PLC - MarketBeatEndpoints NewsStipple Bio launches with $100M to find more precise targets on cancer proteinsEndpoints NewsChina's Syneron raises $150M for peptides, adding to last year's $100MBioPharma DivePerks persuade participantsAgilentAgilent unveils BioTek Cytation 9 Cell Imaging Multimode Reader - biospectrumasia.comThermo FisherThermo Fisher Microscopes: Precision in Scientific Imaging - AD HOC NEWS10x Genomics Blog10x Genomics, Inc. (TXG) stock price, news, quote and history - Yahoo Finance UK
FierceBiotech Apr 6, 2026

March M&A surge triggers high expectations for 2026

March M&A surge triggers high expectations for 2026

Original
Body unavailable. Use the original source.

Directory

59 All